Clinical trials
Withdrawn Phase 2 Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2015 | 2 |
| 2018 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Institute for Regenerative Medicine | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Janssen Pharmaceutical K.K. | 1 |
| Ohr Pharmaceutical Inc. | 1 |
| Snyder, Robert W., M.D., Ph.D., P.C. | 1 |
| University of Padova | 1 |
| Vitreous -Retina- Macula Consultants of New York | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 7 |
| Geographic Atrophy | 2 |
| Choroidal Neovascularization | 1 |
| Vision Disorders | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.